FINWIRES · TerminalLIVE
FINWIRES

Goldman Sachs Upgrades Chugai Pharmaceutical to Buy from Neutral; Price Target is 8,950 Yen

By

Chugai Pharmaceutical (TYO:4519) has an average rating of overweight and mean price target of 10,240 yen, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles